The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management.
Giles I, Thorne I, Schmidt NS, Reid C, Crossley A, Panca M, Freemantle N, Tower C, Dass S, Sharma SK, Williams D, O'Neill S, Dolhain RJEM, Toplak N, Hodson K, Nelson-Piercy C, Clowse MEB.
Giles I, et al. Among authors: dass s.
Lancet Rheumatol. 2024 Jun 11:S2665-9913(24)00097-3. doi: 10.1016/S2665-9913(24)00097-3. Online ahead of print.
Lancet Rheumatol. 2024.
PMID: 38876126
Review.